Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning (Allergen) - Purely Bulk brand Brewer's Yeast recalled due to undeclared peanut


Product photos are available at http://www.inspection.gc.ca/eng/1550102571298/1550102573247

OTTAWA, Feb. 13, 2019 /CNW/ - The food recall warning issued on February 11, 2019 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Puresource Corp. is recalling Purely Bulk brand Brewer's Yeast from the marketplace because it contains peanut which is not declared on the label. People with an allergy to peanut should not consume the recalled product described below. 

The following product has been sold nationally.

Recalled product

 

Brand

Product

Size

UPC

Codes

Purely Bulk

Brewer's Yeast

250 g

0 65279 10054 7

3052916

3072084

3089997

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to peanut do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled products from the marketplace.

Reactions

There have been no reported reactions for the Purely Bulk brand Brewer's yeast. However, a reported reaction has been identified for another branded product that has the same raw material supply as Purely Bulk brand Brewer's Yeast, as reported in the February 7, 2019 Food Recall Warning.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: